In this episode, Dr. Wang Tao joins us to discuss the factors behind China’s shifting role in global supply chains. Dr. Wang explains how China came to play such a dominant role in global manufacturing and the potential consequences of reshoring or moving supply chains elsewhere. She also details the results of a recent survey on North Asia CFOs about intentions to move production out of China, particularly analyzing the COVID-19 pandemic’s role in these decisions. Finally, Dr. Wang speaks to the potential impact of the Hong Kong national security law on supply chain decisions.
In this episode, Dr. Lu Xiang joins us to discuss souring relations between the US and China. Dr. Lu assesses the overall state of the bilateral relationship, and breaks down recent points of friction like the COVID-19 pandemic and the Hong Kong national security law. He also analyzes how the possible outcomes of the 2020 US presidential election might contribute to the improvement or further deterioration of US-China ties. Finally, Dr. Lu shares his expectations for the US-China relationship over the next five to ten years.
Successfully managing the threat of pandemics and epidemics requires advanced capabilities and robust resources. Decades of economic development have enhanced China’s ability to defend against infectious diseases, but the outbreak of COVID-19 laid bare critical health security weaknesses.
In this episode, Dr. Jeremy Youde joins us to discuss China’s evolving role in the World Health Organization (WHO). Dr. Youde outlines how China’s contributions to the WHO have changed over time, and highlights its main sources of influence in the organization. He also explains how the COVID-19 pandemic has exposed some of the challenges that the WHO and the international community face when working with China. Finally, he explores the risk that Taiwan’s exclusion from the WHO poses to global health, and offers insights on Taiwan’s prospects for achieving a greater role in the organization following COVID-19.